Institution statistics

OSLO UNIVERSITETSSYKEHUS HF - Norway 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:400-500
Total Number of Projects:400-500
2018
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:500-600
Total Number of Projects:400-500
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Networking Rank (Reputation):600-700
2015
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:500-600
Project Leadership Index:600-700
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:70
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:400-500
Total Number of Projects:300-400
Total Project Funding:300-400
Networking Rank (Reputation):200-300
Partner Constancy:300-400
Project Leadership Index:300-400
Diversity Index:600-700
2010
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:500-600
Total Number of Projects:900-1000
Total Project Funding:400-500
Networking Rank (Reputation):800-900
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:900-1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Total Project Funding:400-500
Networking Rank (Reputation):600-700
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:400-500
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 56
As coordinator: 5
As participant: 48
Sole participant: 3
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 10.518.219 1.531.835 2
2020 0 44.732.110 3.995.136 7
2019 4.193.644 37.810.259 3.311.561 2 5
2018 1.499.638 21.315.656 2.732.298 1 5
2017 0 8.628.209 962.550 3
2016 11.030.340 19.050.281 3.619.705 3 4
2015 0 41.940.573 2.851.064 5
2014 0 5.999.991 105.300 1
2013 301.251 35.878.913 583.341 1 2
2012 0 9.168.000 695.706 2
2011 417.900 40.078.192 1.871.598 1 8
2010 0 26.372.935 1.352.083 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
KATHOLIEKE UNIVERSITEIT LEUVEN10
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE9
KAROLINSKA INSTITUTE8
REGION HOVEDSTADEN8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
LUNDS UNIVERSITET6
UNIVERSITY OF HELSINKI6
UNIVERSITY OF OSLO6
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM5
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS5
STICHTING KATHOLIEKE UNIVERSITEIT5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
KING'S COLLEGE LONDON4
MEDIZINISCHE UNIVERSITAET WIEN4
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS4
UNIVERSITAETSKLINIKUM HEIDELBERG4
UNIVERSITY OF NEWCASTLE UPON TYNE4
ACADEMISCH ZIEKENHUIS LEIDEN3
CENTRE HOSPITALIER DE LUXEMBOURG3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
CONSIGLIO NAZIONALE DELLE RICERCHE3
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL3
GENOME RESEARCH3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT CURIE3
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
MEDIZINISCHE HOCHSCHULE HANNOVER3
OSPEDALE PEDIATRICO BAMBINO GESU3
OULUN YLIOPISTO3
SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH3
UNIVERSIDAD POLITECNICA DE VALENCIA3
UNIVERSITA DEGLI STUDI DI VERONA3
UNIVERSITAET ZUERICH3
UNIVERSITE LIBRE DE BRUXELLES3
UNIVERSITEIT GENT3
UNIVERSITY OF AARHUS3
ACADEMISCH ZIEKENHUIS GRONINGEN2
ANAXOMICS BIOTECH S L2
CARDIACCS AS2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
DANISH CANCER SOCIETY2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
ELI LILLY AND COMPANY LIMITED2
EUROPEAN CANCER ORGANISATION2
EUROPEAN CANCER PATIENT COALITION2
FAKULTNI NEMOCNICE V MOTOLE2
FOLKEHELSEINSTITUTTET2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
FUNDACION HOSPITAL LA FE2
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
HANNOVERSCHE KINDERHEILANSTALT2
HOSPICES CIVILS DE LYON2
INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL2
INSTITUT DE RADIOPROTECTION ET DE SURETE NUCLEAIRE2
INSTITUT GUSTAVE ROUSSY2
INSTITUT JULES BORDET2
INSTITUT PASTEUR2
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL2
INTERUNIVERSITAIR MICRO ELECTRONICA CENTRUM VZW2
ISTITUTO EUROPEO DI ONCOLOGIA2
JDRF INTERNATIONAL2
LEIDEN UNIVERSITY MEDICAL CENTER2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MEDIZINISCHE UNIVERSITAT GRAZ2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
NATIONAL TECHNICAL UNIVERSITY OF ATHENS NTUA2
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO2
NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY2
NOVARTIS PHARMA2
NOVO NORDISK2
PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV2
PRIVATE UNIVERSITAET WITTEN/HERDECKE GGMBH2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
REGION NORDJYLLAND2
SERVICIO ANDALUZ DE SALUD2
SERVICIO MADRILENO DE SALUD2
STICHTING VUMC2
STROKE ALLIANCE FOR EUROPE2
TECHNISCHE UNIVERSITAET DRESDEN2
THE LEONA M AND HARRY B HELMSLEY CHARITABLE TRUST2
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA2
THE UNIVERSITY OF EDINBURGH2
THE UNIVERSITY OF EXETER2
THE UNIVERSITY OF MANCHESTER2
THE UNIVERSITY OF NOTTINGHAM2
THE UNIVERSITY OF SHEFFIELD2
TROPHOS2
UNIVERCELL BIOSOLUTIONS SAS2
UNIVERSIDAD POMPEU FABRA2
Constancy:

Total number of partners:786

Partner loyalty:
Frequent Partner: (> 2 projects): 176
Rare Partner: 610

Frequent / Rare Partner Ratio: 0.29

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES14
INDUSTRY AND TECHNOLOGY4
RTD HORIZONTAL TOPICS3
SOCIAL AND ECONOMIC CONCERNS3
ENERGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2021-01-01Pancreatic cancer AI for genomics and personalized Medicine PANCAIMparticipant8.236.3799
2020-10-01Directing the immune response through designed nanomaterials DIRNANOparticipant4.027.50112
2020-07-01European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases EU-RESPONSEparticipant15.719.45021
2020-05-01Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA INNODIA HARVESTparticipant5.999.05540
2020-01-01Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity PainFACTparticipant6.000.0007
2020-01-01RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER. RESCUERparticipant6.000.00015
2020-01-01A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients. SMA-TBparticipant6.388.1049
2020-01-01RELIABLE TECHNOLOGIES AND MODELS FOR VERIFIED WIRELESS BODY-CENTRIC TRANSMISSION AND LOCALIZATION ROVERparticipant598.00013
2019-12-01Establishment and Exploitation of a European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer EULAT Eradicate GBCparticipant4.675.93213
2019-10-01Exploitation of the SECRETory pathway for cancer therapy to address European research SECRETparticipant3.955.33911
2019-06-015G HEalth AquacultuRe and Transport validation trials 5G-HEARTparticipant14.322.07422
2019-06-01Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs HARMONICparticipant6.999.98924
2019-06-01Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation GLIOHABcoordinator214.1591
2019-05-01Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies FRINGEcoordinator3.979.4858
2019-01-01ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY iReceptor Plusparticipant7.856.92520
2018-12-01System for AcceleroMeter-Based Assessment of cardiac FUNction SAMBAfunparticipant2.918.3135
2018-06-01MAnufacturing of TUmour-REactive Natural Killer cells MATURE-NKparticipant3.351.66213
2018-02-01EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts EDIReXparticipant5.156.19919
2018-01-01A European Training Network for Functional Hybrid Coatings by Molecular Layer Deposition HYCOATparticipant3.898.79826
2018-01-01Imaging Perfusion Restrictions from Extracellular Solid Stress ImPRESScoordinator1.499.6381
2018-01-01Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial TENSIONparticipant5.990.68515
2017-11-01Empathic, Expressive, Advanced Virtual Coach to Improve Independent Healthy-Life-Years of the Elderly EMPATHICparticipant3.999.80011
2017-09-01Personalised In-Silico Cardiology PICparticipant4.000.56919
2017-04-01FrontierResearchCompentences@CNAP FRESCOatCNAPparticipant627.84015
2016-12-01Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia EU-GliaPhDparticipant3.924.32512
2016-11-01High Performance Soft-tissue Navigation HiPerNavcoordinator4.041.9209
2016-10-01A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours Lumiblastcoordinator3.031.3755
2016-01-01Wireless In-Body Environment WiBECcoordinator3.957.0458
2016-01-01Children’s Liver Tumour European Research Network ChiLTERNparticipant7.941.66523
2016-01-01Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome ALBINOparticipant5.994.03016
2016-01-01Strategies towards Excellence in Immuno-Oncology STREAMparticipant1.190.2615
2015-11-01Intelligent needle tracking using ultrasound imaging for improved minimally invasive interventions INTUI-VIEWparticipant2.361.6973
2015-11-01Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 INNODIAparticipant17.630.00036
2015-09-01INTEGRATED AND ADAPTIVE RESPONSES TO TOXIC EMERGENCIES FOR RAPID TRIAGE: ENGINEERING THE ROADMAP FROM CASUALTY TO PATIENT TO SURVIVOR. TOXI-triageparticipant11.966.51119
2015-06-01PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke PRECIOUSparticipant5.994.00017
2015-06-01MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival MELGENparticipant3.988.3666
2014-02-01Randomised controlled trial to evaluate electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology for patients with cancers ESMARTparticipant5.999.99112
2013-11-01Targeted Action for Curing Trauma Induced Coagulopathy TACTICparticipant5.880.0108
2013-10-01Collaborative European NeuroTrauma Effectiveness Research in TBI CENTER-TBIparticipant29.998.90338
2013-06-07"Evaluation of the synergy between tamoxifen chemotherapy and hypericin photodynamic action, following mitochondrial complex III photo-inhibition: Towards a combinatorial anticancer treatment modality" HYPERTAMcoordinator301.2511
2012-08-01Development of a prophylactic treatment for the prevention of fetal/neonatal alloimmune thrombocytopenia (FNAIT) PROFNAITparticipant5.986.00011
2012-02-01PAtients Leading and mANaging their healThcare through EHealth PALANTEparticipant3.182.00021
2011-12-01Innovative Intracranial Pressure and Volume Wave Monitoring System DynICPparticipant1.125.9918
2011-11-01The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction BAMIparticipant5.993.08322
2011-10-01International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research INTREALLparticipant5.998.05525
2011-08-01"Prevention and improved diagnosis of adolescent genital disease in schistosomiasis endemic KwaZulu-Natal, South Africa" VIBE-FGS-EUSANcoordinator417.9006
2011-03-01Intelligent Surgical Robotics I-SURparticipant2.980.0009
2011-02-01Epidemiological study to quantify risks for paediatric computerized tomography and to optimise doses EPI-CTparticipant2.998.59419
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428

overview shows latest 50 from 56 projects (2010-01-01 - 2021-12-31)
A full list of projects can be found here:

Alias institution names:
  • OSLO UNIVERSITETSSYKEHUS HF

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum